These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24273053)

  • 1. Hepatitis virus hijacks shuttle: exosome-like vesicles provide protection against neutralizing antibodies.
    Ramakrishnaiah V; van der Laan LJ
    Hepatology; 2014 Jun; 59(6):2416-8. PubMed ID: 24273053
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral pathogenesis: Cloak and dagger.
    Hofer U
    Nat Rev Microbiol; 2013 Jun; 11(6):360. PubMed ID: 23588217
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein composition of the hepatitis A virus quasi-envelope.
    McKnight KL; Xie L; González-López O; Rivera-Serrano EE; Chen X; Lemon SM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6587-6592. PubMed ID: 28490497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-like vesicles derived by Schistosoma japonicum adult worms mediates M1 type immune- activity of macrophage.
    Wang L; Li Z; Shen J; Liu Z; Liang J; Wu X; Sun X; Wu Z
    Parasitol Res; 2015 May; 114(5):1865-73. PubMed ID: 25855345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS.
    Zhao X; Wu Y; Duan J; Ma Y; Shen Z; Wei L; Cui X; Zhang J; Xie Y; Liu J
    J Proteome Res; 2014 Dec; 13(12):5391-402. PubMed ID: 25265333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Cellular Membrane Reorganization to Support Hepatitis C Virus Replication.
    Wang H; Tai AW
    Viruses; 2016 May; 8(5):. PubMed ID: 27213428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy.
    Ploen D; Hildt E
    World J Gastroenterol; 2015 Jul; 21(28):8492-507. PubMed ID: 26229393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Baculovirus expression of two human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus].
    Cao JY; Liang MF; Meng QL; Wang XF; Xu YG; Guo KQ; Zhan MY; Bi SL; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):20-3. PubMed ID: 15340519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection.
    Shi J; Sun J; Wang B; Wu M; Zhang J; Duan Z; Wang H; Hu N; Hu Y
    FASEB J; 2014 Oct; 28(10):4381-93. PubMed ID: 25002121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Exosome Protein Content Changes Induced by Virus Activity Using SILAC Labeling and LC-MS/MS.
    Zhao X; Xie Y; Liu J
    Methods Enzymol; 2017; 586():193-209. PubMed ID: 28137563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
    Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
    J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and seroprevalence of hepatitis A virus infections among young Korean soldiers.
    Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
    J Korean Med Sci; 2007 Jun; 22(3):546-8. PubMed ID: 17596668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host neutralizing responses and pathogenesis of hepatitis C virus infection.
    Zeisel MB; Cosset FL; Baumert TF
    Hepatology; 2008 Jul; 48(1):299-307. PubMed ID: 18508291
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
    Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
    J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-associated hepatitis C virus in cell cultures and patient plasma.
    Liu Z; Zhang X; Yu Q; He JJ
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):218-22. PubMed ID: 25449270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A virus: host interactions, molecular epidemiology and evolution.
    Vaughan G; Goncalves Rossi LM; Forbi JC; de Paula VS; Purdy MA; Xia G; Khudyakov YE
    Infect Genet Evol; 2014 Jan; 21():227-43. PubMed ID: 24200587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity.
    Shukla A; Dey D; Banerjee K; Nain A; Banerjee M
    Sci Rep; 2015 Oct; 5():15884. PubMed ID: 26515753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.
    Tami C; Silberstein E; Manangeeswaran M; Freeman GJ; Umetsu SE; DeKruyff RH; Umetsu DT; Kaplan GG
    J Virol; 2007 Apr; 81(7):3437-46. PubMed ID: 17229699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.